作者@article {HodgsonP1.137 = {T。凯塔霍奇森Randy Sanoff和吉莉安Devereux明星Feudi和萨曼莎Cherin霏欧纳地方和罗宾Conwit斯科特·汉密尔顿和合作伙伴Sanossian和西德尼·斯达克曼和Jeffrey节省}title ={影响因素对中风康复的自我相比,客观评估(P1.137)},体积={82}={10}补充数量,elocation-id = {P1.137} ={2014},出版商= {Wolters Kluwer健康,公司代表美国神经病学学会},文摘={目的确定因素占观察中风患者{\ textquoteright}之间客观和主观评估。首页背景:经常有差异中风幸存者{\ textquoteright}复苏的看法和目标尺度用于临床研究的结果,例如,改良Rankin规模(夫人)。这种差异可以受到文化因素和生活方式的影响。我们试图描述的可变性和因素影响自我复苏的一组中风患者参加临床试验评估了研究护士和被认为是自由的严重残疾。设计/方法:现场管理中风Therapy-Magnesium (FAST-MAG)是3期临床试验评估的有效性和安全性prehospital-initiated硫酸镁和安慰剂在改善中风患者的长期功能结果\ < 2小时发病。选择受试者心理状况的考试分数\ > 16和90天的夫人0,1或2,表示最小的残疾。自我批判的复苏程度评估全球复苏规模(GRS), 0 - 100视觉模拟量表在中风影响量表。结果:799例会议标准67岁[SD13]年,38 \ %的女性,22 \ %拉美裔种族,79 \ %白种人,75 \ %高血压和18 \ %糖尿病在招生。GSR的平均分数是90 (IQR 75 - 100)。 (Contrastingly, 469 patients with mRS 3-5, had GRS median 50 [IQR 30-65]). GRS scores varied by mRS rank: mRS 0:GRS 96; mRS 1:GRS 83; mRS 2:GRS 67. There was a weak correlation between older age and higher GRS (R= 0.097, p\<0.001). Among minimally disabled patients, less global recovery was reported by individuals of Hispanic ethnicity [77 vs 84, p\<0.001] and men [81 vs 85, p=0.007]. CONCLUSIONS: Among individuals with minimum post-stroke disability, patient perception of degree of global recovery is strongly influenced by degree of minor residual symptoms and minimum disability. For similar disability levels, lesser degree of recovery is perceived by individuals who are younger, are male, and are of Hispanic ethnicity. Study Supported by: NIH/NINDSDisclosure: Dr. Hodgson has nothing to disclose. Dr. Sanoff has nothing to disclose. Dr. Devereux has nothing to disclose. Dr. Feudi has nothing to disclose. Dr. Cherin has nothing to disclose. Dr. Chatfield has nothing to disclose. Dr. Conwit has nothing to disclose. Dr. Hamilton has nothing to disclose. Dr. Sanossian has received personal compensation for activities with Boehringer-Ingelheim Pharmaceutical Inc. Dr. Starkman has received research support from the National Institutes of Health, Lundbeck, Mitsubishi, and NTI. Dr. Saver has received personal compensation for activities with the University of California, BrainsGate, CoAxia, ev3, Talecris, PhotoThera, Sygnis, and Stryker. Dr. Saver has received research support from the University of California, and the National Institutes of Health.Monday, April 28 2014, 3:00 pm-6:30 pm}, issn = {0028-3878}, URL = {//www.ez-admanager.com/content/82/10_Supplement/P1.137}, eprint = {//www.ez-admanager.com/content}, journal = {Neurology} }